{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T08:58:08Z","timestamp":1740128288542,"version":"3.37.3"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T00:00:00Z","timestamp":1670803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010877","name":"ViiV Healthcare","doi-asserted-by":"publisher","award":["ViiV Healthcare Investigator-Sponsored Study (ISS) funding program"],"award-info":[{"award-number":["ViiV Healthcare Investigator-Sponsored Study (ISS) funding program"]}],"id":[{"id":"10.13039\/100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2023,4]]},"abstract":"<jats:title>Abstract\n<\/jats:title><jats:p>Although increasing research is focusing on age-related comorbidities (ARC) among people living with HIV (PLHIV), no studies have concomitantly assessed non-HIV age-related neurological disorders (e.g., Alzheimer\u2019s dementia). A total of 254 PLHIV and 69 HIV-negative controls completed baseline medical history and cognitive testing. ARC data were collected from medical records over the subsequent 9-10 years and included all types of strokes, all types of dementia, mild cognitive impairment, Parkinson's disease, motor neuron disease (grouped into a non-HIV age-related neurological category), cardiovascular disease, chronic kidney disease, chronic liver disease, chronic lung disease, non-AIDS cancers, osteoporosis, and diabetes. Kaplan\u2013Meier curves assessed differences in the incident rates (per 1000 person year) of groups of ARC as defined above and combined ARC (i.e., development of any of the ARC) among younger (baseline age &lt; 50) and older (baseline age \u2265 50) PLHIV and younger and older controls. Cox-proportional hazard models assessed the individual and interaction effects of HIV status and chronological age, in addition to a range of demographic and clinical variables including historical and baseline HIV brain involvement on the risk of developing combined ARC. Older PLHIV had a higher incidence of cardiovascular disease, osteoporosis, and combined ARC compared to other groups (<jats:italic>p<\/jats:italic> &lt; 0.05). Incident rate of non-HIV age-related neurological disorders was 2.3 [0.93, 4.79] per 1000 person year. While this incident rate was higher in older PLHIV (5.37 [1.97, 11.92]) than older HIV-negative participants (3.58 [0.18-17.67]), this was not significant. In multivariate analyses, HIV status and chronological age, but not their interaction, and smoking were associated with higher risk of combined ARC (<jats:italic>p<\/jats:italic> &lt; 0.05). In analyses focusing on PLHIV, older age and taking abacavir\/efavirenz\/atazanavir\/darunavir containing antiretroviral treatments at the time of diagnosis were associated with greater ARC (<jats:italic>p<\/jats:italic> &lt; 0.05). Non-HIV age-related neurological disorders are uncommon in older PLHIV, where the majority were &lt; 70 years of age at the end of follow-up. However, the greater burden of ARC among older PLHIV, most of which are established dementia risk factors, warrants the establishment of commensurate prevention strategies and greater attention to neurocognitive screening.<\/jats:p>","DOI":"10.1007\/s13365-022-01104-0","type":"journal-article","created":{"date-parts":[[2022,12,12]],"date-time":"2022-12-12T15:03:16Z","timestamp":1670857396000},"page":"141-155","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low incidence of advanced neurological burden but high incidence of age-related conditions that are dementia risk factors in aging people living with HIV: a data-linkage 10-year follow-up study"],"prefix":"10.1007","volume":"29","author":[{"given":"Htein Linn","family":"Aung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bloch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trina","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce J.","family":"Brew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7711-6373","authenticated-orcid":false,"given":"Lucette A.","family":"Cysique","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,12]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1007\/s10461-020-03053-3","volume":"25","author":"HL Aung","year":"2021","unstructured":"Aung HL, Aghvinian M, Gouse H, Robbins RN, Brew BJ, Mao L, Cysique LA (2021a) Is there any evidence of premature, accentuated and accelerated aging effects on neurocognition in people living with HIV? A systematic review. AIDS Behav 25:917\u2013960","journal-title":"AIDS Behav"},{"key":"1104_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/hiv.12980","volume":"22","author":"HL Aung","year":"2021","unstructured":"Aung HL, Bloch M, Vincent T, Quan D, Jayewardene A, Liu Z, Gates TM, Brew B, Mao L, Cysique LA (2021b) Cognitive ageing is premature among a community sample of optimally treated people living with HIV. HIV Med 22:151\u2013164","journal-title":"HIV Med"},{"key":"1104_CR3","doi-asserted-by":"crossref","unstructured":"Aung HL, Gates TM, Mao L, Brew BJ, Rourke SB, Cysique LA (2022) Abnormal cognitive aging in people with HIV: evidence from Data Integration between two countries\u2019 cohort studies. AIDS 10:1097","DOI":"10.1097\/QAD.0000000000003230"},{"key":"1104_CR4","first-page":"227","volume":"10","author":"HL Aung","year":"2019","unstructured":"Aung HL, Kootar S, Gates TM, Brew BJ, Cysique LA (2019) How all-type dementia risk factors and modifiable risk interventions may be relevant to the first-generation aging with HIV infection? Eur Geriatr Med 10:227\u2013238","journal-title":"Eur Geriatr Med"},{"key":"1104_CR5","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1089\/aid.2011.0377","volume":"28","author":"JR Blanco","year":"2012","unstructured":"Blanco JR, Jarr\u00edn I, Vallejo M, Berenguer J, Solera C, Rubio R, Pulido F, Asensi V, del Amo J, Moreno CS (2012) Definition of advanced age in HIV infection: looking for an age cut-off. AIDS Res Hum Retroviruses 28:1000\u20131006","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1104_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/cid\/ciw399","volume":"63","author":"M Bloch","year":"2016","unstructured":"Bloch M, Kamminga J, Jayewardene A, Bailey M, Carberry A, Vincent T, Quan D, Maruff P, Brew B, Cysique LA (2016) A screening strategy for HIV-associated neurocognitive disorders that accurately identifies patients requiring neurological review. Clin Infect Dis 63:687\u2013693","journal-title":"Clin Infect Dis"},{"key":"1104_CR7","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.2105\/AJPH.2012.300844","volume":"102","author":"JT Brooks","year":"2012","unstructured":"Brooks JT, Buchacz K, Gebo KA, Mermin J (2012) HIV infection and older Americans: the public health perspective. Am J Public Health 102:1516\u20131526","journal-title":"Am J Public Health"},{"key":"1104_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/joim.12843","volume":"285","author":"A Calder\u00f3n-Larra\u00f1aga","year":"2019","unstructured":"Calder\u00f3n-Larra\u00f1aga A, Vetrano DL, Ferrucci L, Mercer SW, Marengoni A, Onder G, Eriksdotter M, Fratiglioni L (2019) Multimorbidity and functional impairment\u2013bidirectional interplay, synergistic effects and common pathways. J Intern Med 285:255\u2013271","journal-title":"J Intern Med"},{"key":"1104_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.bjid.2012.11.007","volume":"17","author":"SW Cardoso","year":"2013","unstructured":"Cardoso SW, Torres TS, Santini-Oliveira M, Marins LMS, Veloso VG, Grinsztejn B (2013) Aging with HIV: a practical review. Braz J Infect Dis 17:464\u2013479","journal-title":"Braz J Infect Dis"},{"key":"1104_CR10","doi-asserted-by":"publisher","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","volume":"12","author":"A Carr","year":"1998","unstructured":"Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12:F51\u2013F58","journal-title":"AIDS"},{"key":"1104_CR11","first-page":"423","volume":"29","author":"P Chan","year":"2022","unstructured":"Chan P, Valcour V (2022) Neurocognition and the aging brain in people with HIV: implications for screening. Top Antivir Med 29:423\u2013429","journal-title":"Top Antivir Med"},{"key":"1104_CR12","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40121-018-0201-6","volume":"7","author":"A Chawla","year":"2018","unstructured":"Chawla A, Wang C, Patton C, Murray M, Punekar Y, de Ruiter A, Steinhart C (2018) A review of long-term toxicity of antiretroviral treatment regimens and implications for an aging population. Infectious Diseases and Therapy 7:183\u2013195","journal-title":"Infectious Diseases and Therapy"},{"key":"1104_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/QAD.0b013e32834f324b","volume":"26","author":"K Childs","year":"2012","unstructured":"Childs K, Welz T, Samarawickrama A, Post FA (2012) Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS 26:253\u2013262","journal-title":"AIDS"},{"key":"1104_CR14","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1097\/QAD.0b013e328347fa16","volume":"25","author":"AI Choi","year":"2011","unstructured":"Choi AI, Vittinghoff E, Deeks SG, Weekley CC, Li Y, Shlipak MG (2011) Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons. AIDS (london, England) 25:1289\u20131298","journal-title":"AIDS (london, England)"},{"key":"1104_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13195-015-0123-4","volume":"7","author":"RA Cohen","year":"2015","unstructured":"Cohen RA, Seider TR, Navia B (2015) HIV effects on age-associated neurocognitive dysfunction: premature cognitive aging or neurodegenerative disease? Alzheimers Res Ther 7:37","journal-title":"Alzheimers Res Ther"},{"key":"1104_CR16","unstructured":"Cuzick J (1999) Interaction, subgroup analysis and sample size. IARC Sci Publ: 109\u201321"},{"key":"1104_CR17","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1007\/s13365-018-0706-5","volume":"25","author":"LA Cysique","year":"2019","unstructured":"Cysique LA, Brew BJ (2019) Vascular cognitive impairment and HIV-associated neurocognitive disorder: a new paradigm. J Neurovirol 25:710\u2013721","journal-title":"J Neurovirol"},{"key":"1104_CR18","first-page":"983","volume":"24","author":"LA Cysique","year":"2010","unstructured":"Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson ISJA (2010) Incidence and Nature of Cognitive Decline over One Year among HIV-Infected Former Plasma Donors in China 24:983","journal-title":"Incidence and Nature of Cognitive Decline over One Year among HIV-Infected Former Plasma Donors in China"},{"key":"1104_CR19","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.acn.2005.07.011","volume":"21","author":"LA Cysique","year":"2006","unstructured":"Cysique LA, Maruff P, Darby D, Brew BJ (2006) The assessment of cognitive function in advanced HIV-1 infection and AIDS dementia complex using a new computerised cognitive test battery. Arch Clin Neuropsychol 21:185\u2013194","journal-title":"Arch Clin Neuropsychol"},{"key":"1104_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0144286","volume":"10","author":"JA Dave","year":"2015","unstructured":"Dave JA, Cohen K, Micklesfield LK, Maartens G, Levitt NS (2015) Antiretroviral therapy, especially efavirenz, is associated with low bone mineral density in HIV-infected South Africans. PLoS ONE 10:e0144286","journal-title":"PLoS ONE"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1097\/HJR.0b013e328336a150","volume":"17","author":"N Friis-M\u00f8ller","year":"2010","unstructured":"Friis-M\u00f8ller N, Thiebaut R, Reiss P, Weber R, D\u2019Arminio Monforte A, De Wit S, El-Sadr W, Fontas E, Worm S, Kirk O (2010) Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil 17:491\u2013501","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"1104_CR22","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1086\/523577","volume":"45","author":"JL Goulet","year":"2007","unstructured":"Goulet JL, Fultz SL, Rimland D, Butt A, Gibert C, Rodriguez-Barradas M, Bryant K, Justice AC (2007) Do patterns of comorbidity vary by HIV status, age, and hiv severity? Clin Infect Dis 45:1593\u20131601","journal-title":"Clin Infect Dis"},{"key":"1104_CR23","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","volume":"82","author":"I Grant","year":"2014","unstructured":"Grant I, Franklin DR, Deutsch R, Woods SP, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Smith DM, Heaton RK (2014) Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology 82:2055\u20132062","journal-title":"Neurology"},{"key":"1104_CR24","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1093\/cid\/cir627","volume":"53","author":"G Guaraldi","year":"2011","unstructured":"Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E, Berti A, Rossi E, Roverato A, Palella F (2011) Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis 53:1120\u20131126","journal-title":"Clin Infect Dis"},{"issue":"Suppl 2","key":"1104_CR25","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1097\/QAD.0000000000001478","volume":"31","author":"G Guaraldi","year":"2017","unstructured":"Guaraldi G, Palella FJ Jr (2017) Clinical implications of aging with HIV infection: perspectives and the future medical care agenda. AIDS 31(Suppl 2):S129-s135","journal-title":"AIDS"},{"key":"1104_CR26","first-page":"75","volume":"16","author":"G Guaraldi","year":"2014","unstructured":"Guaraldi G, Prakash M, Moecklinghoff C, Stellbrink H-J (2014) Morbidity in older HIV-infected patients: impact of long-term antiretroviral use. AIDS Rev 16:75\u201389","journal-title":"AIDS Rev"},{"key":"1104_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3851\/IMP3293","volume":"24","author":"MO Halloran","year":"2019","unstructured":"Halloran MO, Boyle C, Kehoe B, Bagkeris E, Mallon P, Post FA, Vera J, Williams I, Anderson J, Winston A (2019) Polypharmacy and drug\u2013drug interactions in older and younger people living with HIV: the POPPY study. Antivir Ther 24:193\u2013201","journal-title":"Antivir Ther"},{"key":"1104_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1093\/eurheartj\/eht462","volume":"35","author":"DL Hare","year":"2014","unstructured":"Hare DL, Toukhsati SR, Johansson P, Jaarsma T (2014) Depression and cardiovascular disease: a clinical review. Eur Heart J 35:1365\u20131372","journal-title":"Eur Heart J"},{"key":"1104_CR29","doi-asserted-by":"crossref","unstructured":"Hasse B, Ledergerber B, Furrer H, Battegay M, Hirschel B, Cavassini M, Bertisch B, Bernasconi E, Weber R, Study tSHC (2011) Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 53: 1130-1139","DOI":"10.1093\/cid\/cir626"},{"key":"1104_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1017\/S1355617704102130","volume":"10","author":"RK Heaton","year":"2004","unstructured":"Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I, GROUP H, (2004) The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 10:317\u2013331","journal-title":"J Int Neuropsychol Soc"},{"key":"1104_CR31","doi-asserted-by":"crossref","unstructured":"Hove-Skovsgaard M, Zhao Y, Tingstedt JL, Hartling HJ, Thudium RF, Benfield T, Afzal S, Nordestgaard B, Ullum H, Gerstoft J, Mocroft A, Nielsen SD (2020) Impact of age and HIV status on immune activation, senescence and apoptosis. Front Immunol 11","DOI":"10.3389\/fimmu.2020.583569"},{"key":"1104_CR32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1503\/cmaj.131626","volume":"187","author":"CA Hughes","year":"2015","unstructured":"Hughes CA, Tseng A, Cooper R (2015) Managing drug interactions in HIV-infected adults with comorbid illness. CMAJ 187:36\u201343","journal-title":"CMAJ"},{"key":"1104_CR33","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s11904-010-0041-9","volume":"7","author":"AC Justice","year":"2010","unstructured":"Justice AC (2010) HIV and aging: time for a new paradigm. Curr HIV\/AIDS Rep 7:69\u201376","journal-title":"Curr HIV\/AIDS Rep"},{"key":"1104_CR34","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1080\/13803395.2016.1263282","volume":"39","author":"J Kamminga","year":"2017","unstructured":"Kamminga J, Bloch M, Vincent T, Carberry A, Brew BJ, Cysique LA (2017) Determining optimal impairment rating methodology for a new HIV-associated neurocognitive disorder screening procedure. J Clin Exp Neuropsychol 39:753\u2013767","journal-title":"J Clin Exp Neuropsychol"},{"key":"1104_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1089\/apc.2018.0190","volume":"33","author":"AM Kong","year":"2019","unstructured":"Kong AM, Pozen A, Anastos K, Kelvin EA, Nash D (2019) Non-HIV comorbid conditions and polypharmacy among people living with HIV age 65 or older compared with HIV-negative individuals age 65 or older in the United States: a retrospective claims-based analysis. AIDS Patient Care STDS 33:93\u2013103","journal-title":"AIDS Patient Care STDS"},{"key":"1104_CR36","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1097\/QAD.0000000000002806","volume":"35","author":"JO Lam","year":"2021","unstructured":"Lam JO, Hou CE, Hojilla JC, Anderson AN, Gilsanz P, Alexeeff SE, Levine-Hall T, Hood N, Lee C, Satre DD, Silverberg MJ (2021) Comparison of dementia risk after age 50 between individuals with and without HIV infection. AIDS 35:821\u2013828","journal-title":"AIDS"},{"key":"1104_CR37","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-011146","volume":"7","author":"L Lang","year":"2017","unstructured":"Lang L, Clifford A, Wei L, Zhang D, Leung D, Augustine G, Danat IM, Zhou W, Copeland JR, Anstey KJ (2017) Prevalence and determinants of undetected dementia in the community: a systematic literature review and a meta-analysis. BMJ Open 7:e011146","journal-title":"BMJ Open"},{"key":"1104_CR38","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/01.qai.0000247229.68246.c5","volume":"44","author":"B Lau","year":"2007","unstructured":"Lau B, Gange SJ, Moore RD (2007) Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells\/mm3. JAIDS J Acq Immun Defic Syndrom 44:179\u2013187","journal-title":"JAIDS J Acq Immun Defic Syndrom"},{"key":"1104_CR39","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.016310","volume":"9","author":"M Li","year":"2020","unstructured":"Li M, Chan WW, Zucker SD (2020) Association between Atazanavir\u2010induced hyperbilirubinemia and cardiovascular disease in patients infected with HIV. J Am Heart Assoc 9:e016310","journal-title":"J Am Heart Assoc"},{"key":"1104_CR40","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjcard.2004.03.023","volume":"94","author":"DM Lloyd-Jones","year":"2004","unstructured":"Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D\u2019Agostino RB, Levy D (2004) Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 94:20\u201324","journal-title":"Am J Cardiol"},{"key":"1104_CR41","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1093\/ageing\/afg097","volume":"32","author":"M L\u00f6pp\u00f6nen","year":"2003","unstructured":"L\u00f6pp\u00f6nen M, R\u00e4ih\u00e4 I, Isoaho R, Vahlberg T, Kivel\u00e4 S-L (2003) Diagnosing cognitive impairment and dementia in primary health care\u2013a more active approach is needed. Age Ageing 32:606\u2013612","journal-title":"Age Ageing"},{"key":"1104_CR42","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-U","volume":"33","author":"PF Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH (1995) The structure of negative emotional states: comparison of the Depression Anxiety Stress Scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther 33:335\u2013343","journal-title":"Behav Res Ther"},{"key":"1104_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/j.1468-1293.2007.00534.x","volume":"9","author":"JD Lundgren","year":"2008","unstructured":"Lundgren JD, Battegay M, Behrens G, De Wit S, Guaraldi G, Katlama C, Martinez E, Nair D, Powderly WG, Reiss P (2008) European AIDS Clinical Society (EACS) guidelines on the prevention and management of metabolic diseases in HIV. HIV Med 9:72\u201381","journal-title":"HIV Med"},{"key":"1104_CR44","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijid.2018.02.009","volume":"70","author":"RA Maciel","year":"2018","unstructured":"Maciel RA, Kl\u00fcck HM, Durand M, Sprinz E (2018) Comorbidity is more common and occurs earlier in persons living with HIV than in HIV-uninfected matched controls, aged 50 years and older: a cross-sectional study. Int J Infect Dis 70:30\u201335","journal-title":"Int J Infect Dis"},{"key":"1104_CR45","volume":"2015","author":"CI Marinescu","year":"2015","unstructured":"Marinescu CI, Leyes M, Ribas MA, Pe\u00f1aranda M, Murillas J, Campins AA, Martin-Pena L, Barcelo B, Barcel\u00f3-Campomar C, Grases F, Frontera G, Riera Jaume M (2015) Relationships between serum levels of atazanavir and renal toxicity or lithiasis. AIDS Res Treat 2015:106954","journal-title":"AIDS Res Treat"},{"key":"1104_CR46","doi-asserted-by":"crossref","unstructured":"Mart\u00ednez-Sanz J, Serrano-Villar S, Vivancos MJ, Rubio R, Moreno S, Group H-acS (2021) Management of comorbidities in treated HIV infection: a long way to go: HIV, comorbidities and aging. Int J Antimicrob Agents 106493","DOI":"10.1016\/j.ijantimicag.2021.106493"},{"key":"1104_CR47","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1097\/QAD.0b013e328339fe53","volume":"24","author":"A Mocroft","year":"2010","unstructured":"Mocroft A, Kirk O, Reiss P, De Wit S, Sedlacek D, Beniowski M, Gatell J, Phillips AN, Ledergerber B, Lundgren JD (2010) Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS 24:1667\u20131678","journal-title":"AIDS"},{"key":"1104_CR48","unstructured":"Montoya JL (2018) Vascular contributions to neurocognitive impairment among older persons with HIV. Dissert Abs Int: Sect B: Sci Eng 79"},{"key":"1104_CR49","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1086\/592115","volume":"47","author":"RD Moore","year":"2008","unstructured":"Moore RD, Gebo KA, Lucas GM, Keruly JC (2008) Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status. Clin Infect Dis 47:1102\u20131104","journal-title":"Clin Infect Dis"},{"key":"1104_CR50","doi-asserted-by":"publisher","first-page":"232595821984190","DOI":"10.1177\/2325958219841908","volume":"18","author":"E Muya","year":"2019","unstructured":"Muya E, Kamuhabwa A (2019) Comparative assessment of the magnitude of hyperlipidemia in HIV-infected patients receiving lopinavir\/r-and atazanavir\/r-based antiretroviral drugs. Journal of the International Association of Providers of AIDS Care (JIAPAC) 18:2325958219841908","journal-title":"Journal of the International Association of Providers of AIDS Care (JIAPAC)"},{"key":"1104_CR51","doi-asserted-by":"publisher","first-page":"S55","DOI":"10.1097\/QAD.0b013e3283558459","volume":"26","author":"J Negin","year":"2012","unstructured":"Negin J, Martiniuk A, Cumming RG, Naidoo N, Phaswana-Mafuya N, Madurai L, Williams S, Kowal P (2012) Prevalence of HIV and chronic comorbidities among older adults. AIDS (london, England) 26:S55","journal-title":"AIDS (london, England)"},{"key":"1104_CR52","doi-asserted-by":"publisher","first-page":"5897298","DOI":"10.1155\/2017\/5897298","volume":"2017","author":"E Negredo","year":"2017","unstructured":"Negredo E, Back D, Blanco JR, Blanco J, Erlandson KM, Garolera M, Guaraldi G, Mallon P, Molto J, Serra JA, Clotet B (2017) Aging in HIV-infected subjects: a new scenario and a new view. Biomed Res Int 2017:5897298","journal-title":"Biomed Res Int"},{"key":"1104_CR53","doi-asserted-by":"publisher","first-page":"e105","DOI":"10.1016\/S2468-2667(21)00249-8","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, Abdoli A, Abualhasan A, Abu-Gharbieh E, Akram TT, Al Hamad H, Alahdab F, Alanezi FM, Alipour V, Almustanyir S, Amu H, Ansari I, Arabloo J, Ashraf T, Astell-Burt T, Ayano G, Ayuso-Mateos JL, Baig AA, Barnett A, Barrow A, Baune BT, B\u00e9jot Y, Bezabhe WMM, Bezabih YM, Bhagavathula AS, Bhaskar S, Bhattacharyya K, Bijani A, Biswas A, Bolla SR, Boloor A, Brayne C, Brenner H, Burkart K, Burns RA, C\u00e1mera LA, Cao C, Carvalho F, Castro-de-Araujo LFS, Catal\u00e1-L\u00f3pez F, Cerin E, Chavan PP, Cherbuin N, Chu D-T, Costa VM, Couto RAS, Dadras O, Dai X, Dandona L, Dandona R, De la Cruz-G\u00f3ngora V, Dhamnetiya D, Dias da Silva D, Diaz D, Douiri A, Edvardsson D, Ekholuenetale M, El Sayed I, El-Jaafary SI, Eskandari K, Eskandarieh S, Esmaeilnejad S, Fares J, Faro A, Farooque U, Feigin VL, Feng X, Fereshtehnejad S-M, Fernandes E, Ferrara P, Filip I, Fillit H, Fischer F, Gaidhane S, Galluzzo L, Ghashghaee A, Ghith N, Gialluisi A, Gilani SA, Glavan I-R, Gnedovskaya EV, Golechha M, Gupta R, Gupta VB, Gupta VK, Haider MR, Hall BJ, Hamidi S, Hanif A, Hankey GJ, Haque S, Hartono RK, Hasaballah AI, Hasan MT, Hassan A et al (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7:e105\u2013e125","journal-title":"Lancet Public Health"},{"key":"1104_CR54","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/S1474-4422(14)70137-1","volume":"13","author":"S Nightingale","year":"2014","unstructured":"Nightingale S, Winston A, Letendre S, Michael BD, McArthur JC, Khoo S, Solomon T (2014) Controversies in HIV-associated neurocognitive disorders. Lancet Neurol 13:1139\u20131151","journal-title":"Lancet Neurol"},{"key":"1104_CR55","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1310\/hct1102-100","volume":"11","author":"NF Onen","year":"2010","unstructured":"Onen NF, Overton ET, Seyfried W, Stumm ER, Snell M, Mondy K, Tebas P (2010) Aging and HIV infection: a comparison between older HIV-infected persons and the general population. HIV Clin Trials 11:100\u2013109","journal-title":"HIV Clin Trials"},{"key":"1104_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","volume":"43","author":"FJ Palella Jr","year":"2006","unstructured":"Palella FJ Jr, Baker RK, Moorman AC, Chmiel JS, Wood KC, Brooks JT, Holmberg SD, Investigators HOS (2006) Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. JAIDS J Acq Immun Defic Syndrom 43:27\u201334","journal-title":"JAIDS J Acq Immun Defic Syndrom"},{"key":"1104_CR57","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.critrevonc.2008.01.013","volume":"67","author":"JF Piccirillo","year":"2008","unstructured":"Piccirillo JF, Vlahiotis A, Barrett LB, Flood KL, Spitznagel EL, Steyerberg EW (2008) The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 67:124\u2013132","journal-title":"Crit Rev Oncol Hematol"},{"key":"1104_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-018-3144-9","volume":"11","author":"G Rankgoane-Pono","year":"2018","unstructured":"Rankgoane-Pono G, Tshikuka JG, Magafu MGMD, Masupe T, Molefi M, Hamda SG, Setlhare V, Tapera R, Mbongwe B (2018) Incidence of diabetes mellitus-related comorbidities among patients attending two major HIV clinics in Botswana: a 12-year retrospective cohort study. BMC Res Notes 11:1\u20135","journal-title":"BMC Res Notes"},{"key":"1104_CR59","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1093\/cid\/civ118","volume":"60","author":"LD Rasmussen","year":"2015","unstructured":"Rasmussen LD, Helleberg M, May MT, Afzal S, Kronborg G, Larsen CS, Pedersen C, Gerstoft J, Nordestgaard BG, Obel N (2015) Myocardial infarction among Danish HIV-infected individuals: population-attributable fractions associated with smoking. Clin Infect Dis 60:1415\u20131423","journal-title":"Clin Infect Dis"},{"key":"1104_CR60","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1097\/00126334-200312010-00004","volume":"34","author":"RB Reisler","year":"2003","unstructured":"Reisler RB, Han C, Burman WJ, Tedaldi EM, Neaton JD (2003) Grade 4 events are as important as AIDS events in the era of HAART. JAIDS J Acq Immun Defic Syndrom 34:379\u2013386","journal-title":"JAIDS J Acq Immun Defic Syndrom"},{"key":"1104_CR61","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/QAD.0000000000002709","volume":"35","author":"SB Rourke","year":"2021","unstructured":"Rourke SB, Bekele T, Rachlis A, Kovacs C, Brunetta J, Gill MJ, Carvalhal A, Cysique LA, Marcotte T, Power C (2021) Asymptomatic neurocognitive impairment is a risk for symptomatic decline over a 3-year study period. AIDS 35:63\u201372","journal-title":"AIDS"},{"key":"1104_CR62","doi-asserted-by":"crossref","unstructured":"Ryom L, Lundgren JD, El-Sadr W, Reiss P, Kirk O, Law M, Phillips A, Weber R, Fontas E, d' Arminio Monforte A, De Wit S, Dabis F, Hatleberg CI, Sabin C, Mocroft A (2018) Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study. The Lancet HIV 5: e291-e300","DOI":"10.1016\/S2352-3018(18)30043-2"},{"key":"1104_CR63","unstructured":"Sartorius N (2022) Depression and diabetes. Dialogues Clin Neurosci"},{"key":"1104_CR64","doi-asserted-by":"crossref","unstructured":"Serr\u00e3o R, Pi\u00f1ero C, Velez J, Coutinho D, Maltez F, Lino S, Sarmento e Castro R, Tavares AP, Pacheco P, Lopes MJ, Mansinho K, Miranda AC, Neves I, Correia de Abreu R, Almeida J, P\u00e1ssaro L (2019) Non-AIDS-related comorbidities in people living with HIV-1 aged 50 years and older: The AGING POSITIVE study. Int J Infect Dis 79: 94-100","DOI":"10.1016\/j.ijid.2018.10.011"},{"key":"1104_CR65","doi-asserted-by":"crossref","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psych","DOI":"10.1037\/t18597-000"},{"key":"1104_CR66","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/s13365-017-0523-2","volume":"23","author":"DP Sheppard","year":"2017","unstructured":"Sheppard DP, Iudicello JE, Morgan EE, Kamat R, Clark LR, Avci G, Bondi MW, Woods SP (2017) Accelerated and accentuated neurocognitive aging in HIV infection. J Neurovirol 23:492\u2013500","journal-title":"J Neurovirol"},{"key":"1104_CR67","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1037\/neu0000191","volume":"29","author":"NS Thaler","year":"2015","unstructured":"Thaler NS, Sayegh P, Arentoft A, Thames AD, Castellon SA, Hinkin CH (2015) Increased neurocognitive intra-individual variability is associated with declines in medication adherence in HIV-infected adults. Neuropsychology 29:919","journal-title":"Neuropsychology"},{"key":"1104_CR68","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1089\/aid.2005.21.706","volume":"21","author":"V Tozzi","year":"2005","unstructured":"Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME (2005) Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses 21:706\u2013713","journal-title":"AIDS Res Hum Retroviruses"},{"key":"1104_CR69","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1017\/S1355617710001438","volume":"17","author":"V Valcour","year":"2011","unstructured":"Valcour V, Paul R, Neuhaus J, Shikuma C (2011) The effects of age and HIV on neuropsychological performance. [References]. J Int Neuropsychol Soc 17:190\u2013195","journal-title":"J Int Neuropsychol Soc"},{"key":"1104_CR70","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.idc.2017.07.007","volume":"31","author":"P Van Epps","year":"2017","unstructured":"Van Epps P, Kalayjian RC (2017) Human immunodeficiency virus and aging in the era of effective antiretroviral therapy. Infect Dis Clin North Am 31:791\u2013810","journal-title":"Infect Dis Clin North Am"},{"key":"1104_CR71","first-page":"1150","volume":"75","author":"P Vivithanaporn","year":"2010","unstructured":"Vivithanaporn P, Heo G, Gamble J, Krentz HB, Hoke A, Gill MJ, Power C (2010) Neurologic disease burden in treated HIV\/AIDS predicts survival. A Population-Based Study 75:1150\u20131158","journal-title":"A Population-Based Study"},{"key":"1104_CR72","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.ijid.2016.10.004","volume":"53","author":"EJ Wing","year":"2016","unstructured":"Wing EJ (2016) HIV and aging. Int J Infect Dis 53:61\u201368","journal-title":"Int J Infect Dis"},{"key":"1104_CR73","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1086\/649897","volume":"201","author":"SW Worm","year":"2010","unstructured":"Worm SW, Sabin C, Weber R, Reiss P, El-Sadr W, Dabis F, De Wit S, Law M, Monforte ADA, Friis-M\u00f8ller N, Kirk O, Fontas E, Weller I, Phillips A, Lundgren J (2010) Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis 201:318\u2013330","journal-title":"J Infect Dis"},{"key":"1104_CR74","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1212\/WNL.0b013e3181f11bd8","volume":"75","author":"EJ Wright","year":"2010","unstructured":"Wright EJ, Grund B, Robertson K, Brew BJ, Roediger M, Bain MP, Drummond F, Vjecha MJ, Hoy J, Miller C, Penalva de Oliveira AC, Pumpradit W, Shlay JC, El-Sadr W, Price RW (2010) Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons. Neurology 75:864\u2013873","journal-title":"Neurology"},{"key":"1104_CR75","doi-asserted-by":"crossref","unstructured":"Yang X, Zhang J, Chen S, Weissman S, Olatosi B, Li X (2021) Utilizing electronic health record data to understand comorbidity burden among people living with HIV: a machine learning approach. LWW, pp S39-S51","DOI":"10.1097\/QAD.0000000000002736"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13365-022-01104-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-022-01104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T16:30:48Z","timestamp":1684168248000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13365-022-01104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,12]]},"references-count":75,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s13365-022-01104-0","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"type":"print","value":"1355-0284"},{"type":"electronic","value":"1538-2443"}],"subject":[],"published":{"date-parts":[[2022,12,12]]},"assertion":[{"value":"1 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received ethics approval from the St. Vincent\u2019s Hospital Human Research Ethics Committee (2021\/ETH00184).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Bruce J. Brew received speaker honorarium from Janssen. Mark Bloch received funds for medical advisory boards and educational meetings from Gilead Sciences, Abbvie, Janssen, and ViiV Healthcare. He also received funding for research from Gilead Sciences, ViiV Healthcare, MSD, Abbvie, and GSK. All the other authors declare no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}